Klyne
@klyneai.bsky.social
Transforming drug discovery with ultra-large screening, AI-powered molecular design, and precise binding energy calculations. Accessible biotech solutions for all 🌟
Got biotech software needs? Contact us: [email protected] —we're here to help!
Got biotech software needs? Contact us: [email protected] —we're here to help!
💥 Drug discovery software is broken
Customers pay big fees for tools that may not work
👉🏽 We started KlyneAI to build tailored tools for your challenges—not generic ones
No sugar-coating. If it doesn’t work, we stop—you don’t waste money.Time for an honest, problem-driven approach to drug discovery
Customers pay big fees for tools that may not work
👉🏽 We started KlyneAI to build tailored tools for your challenges—not generic ones
No sugar-coating. If it doesn’t work, we stop—you don’t waste money.Time for an honest, problem-driven approach to drug discovery
May 1, 2025 at 11:36 PM
💥 Drug discovery software is broken
Customers pay big fees for tools that may not work
👉🏽 We started KlyneAI to build tailored tools for your challenges—not generic ones
No sugar-coating. If it doesn’t work, we stop—you don’t waste money.Time for an honest, problem-driven approach to drug discovery
Customers pay big fees for tools that may not work
👉🏽 We started KlyneAI to build tailored tools for your challenges—not generic ones
No sugar-coating. If it doesn’t work, we stop—you don’t waste money.Time for an honest, problem-driven approach to drug discovery
Check out this hot take from our CTO 👇
At Klyne, we focus on practical, results-driven drug discovery—for most clients, ultra-large virtual screening (trillions of compounds 🌐) makes sense with conventional docking. It’s fast, scalable, and gets the job done
Curious to learn more? [[email protected]]
At Klyne, we focus on practical, results-driven drug discovery—for most clients, ultra-large virtual screening (trillions of compounds 🌐) makes sense with conventional docking. It’s fast, scalable, and gets the job done
Curious to learn more? [[email protected]]
Hot take in drug discovery: The real value of molecular docking lies in ranking for (ultra-large) virtual screening.
Structure co-folding models with ligands? Super cool! But unless they prove themselves in screening performance, conventional docking still wins 🤔
Structure co-folding models with ligands? Super cool! But unless they prove themselves in screening performance, conventional docking still wins 🤔
April 27, 2025 at 4:08 PM
Check out this hot take from our CTO 👇
At Klyne, we focus on practical, results-driven drug discovery—for most clients, ultra-large virtual screening (trillions of compounds 🌐) makes sense with conventional docking. It’s fast, scalable, and gets the job done
Curious to learn more? [[email protected]]
At Klyne, we focus on practical, results-driven drug discovery—for most clients, ultra-large virtual screening (trillions of compounds 🌐) makes sense with conventional docking. It’s fast, scalable, and gets the job done
Curious to learn more? [[email protected]]
🚀 Big news from Klyne!
We’re thrilled to be collaborating with @cgorgulla.bsky.social ky.social's lab to develop the next generation of tools for accelerating drug discovery.
Stay tuned—some exciting papers are on the way from this collaboration!
We’re thrilled to be collaborating with @cgorgulla.bsky.social ky.social's lab to develop the next generation of tools for accelerating drug discovery.
Stay tuned—some exciting papers are on the way from this collaboration!
April 23, 2025 at 1:23 AM
🚀 Big news from Klyne!
We’re thrilled to be collaborating with @cgorgulla.bsky.social ky.social's lab to develop the next generation of tools for accelerating drug discovery.
Stay tuned—some exciting papers are on the way from this collaboration!
We’re thrilled to be collaborating with @cgorgulla.bsky.social ky.social's lab to develop the next generation of tools for accelerating drug discovery.
Stay tuned—some exciting papers are on the way from this collaboration!
🚀 Exciting News! 🚀
KlyneAI is thrilled to join JLABS! We’re pushing the boundaries of biotech innovation and developing cutting-edge tools for drug discovery.
Want to collaborate on AI-driven drug discovery?
→ [email protected]
#Biotech #DrugDiscovery #AI #JLabs
(Yes, the view’s amazing) 🤩
KlyneAI is thrilled to join JLABS! We’re pushing the boundaries of biotech innovation and developing cutting-edge tools for drug discovery.
Want to collaborate on AI-driven drug discovery?
→ [email protected]
#Biotech #DrugDiscovery #AI #JLabs
(Yes, the view’s amazing) 🤩
February 25, 2025 at 7:15 PM
🚀 Exciting News! 🚀
KlyneAI is thrilled to join JLABS! We’re pushing the boundaries of biotech innovation and developing cutting-edge tools for drug discovery.
Want to collaborate on AI-driven drug discovery?
→ [email protected]
#Biotech #DrugDiscovery #AI #JLabs
(Yes, the view’s amazing) 🤩
KlyneAI is thrilled to join JLABS! We’re pushing the boundaries of biotech innovation and developing cutting-edge tools for drug discovery.
Want to collaborate on AI-driven drug discovery?
→ [email protected]
#Biotech #DrugDiscovery #AI #JLabs
(Yes, the view’s amazing) 🤩
Check out this great interview with the incredible @aspuru.bsky.social on BNNBloomberg, highlighting a recent publication co-authored by our CTO,
@akshatai.bsky.social ! [Paper: rdcu.be/d68Fs]
Exciting times ahead for Klyne—stay tuned for more! 🚀🔬
t.co/tkLsgjcSDb
@akshatai.bsky.social ! [Paper: rdcu.be/d68Fs]
Exciting times ahead for Klyne—stay tuned for more! 🚀🔬
t.co/tkLsgjcSDb
https://www.bnnbloomberg.ca/video/shows/the-close/2025/02/05/how-researchers-are-using-quantum-computing-to-target-an-undruggable-cancer-protein/
t.co
February 6, 2025 at 8:13 PM
Check out this great interview with the incredible @aspuru.bsky.social on BNNBloomberg, highlighting a recent publication co-authored by our CTO,
@akshatai.bsky.social ! [Paper: rdcu.be/d68Fs]
Exciting times ahead for Klyne—stay tuned for more! 🚀🔬
t.co/tkLsgjcSDb
@akshatai.bsky.social ! [Paper: rdcu.be/d68Fs]
Exciting times ahead for Klyne—stay tuned for more! 🚀🔬
t.co/tkLsgjcSDb
🚀 Big news from Klyne!
Check out our CTO’s work—the first quantum generative model for hit discovery!
At Klyne, we build affordable tools for drug discovery:
✨ Pay-as-you-go (no licensing fees, ~10x cheaper)
💡 Expert team for every stage
📩 [[email protected]]
Check out our CTO’s work—the first quantum generative model for hit discovery!
At Klyne, we build affordable tools for drug discovery:
✨ Pay-as-you-go (no licensing fees, ~10x cheaper)
💡 Expert team for every stage
📩 [[email protected]]
Excited to share our latest work, published this morning in Nature Biotechnology! 🎉 We developed a hybrid quantum computing-enhanced generative model to design KRAS inhibitors. Check it out here: rdcu.be/d68Fs.
Some fascinating insights along the way:
Some fascinating insights along the way:
January 23, 2025 at 3:09 AM
🚀 Big news from Klyne!
Check out our CTO’s work—the first quantum generative model for hit discovery!
At Klyne, we build affordable tools for drug discovery:
✨ Pay-as-you-go (no licensing fees, ~10x cheaper)
💡 Expert team for every stage
📩 [[email protected]]
Check out our CTO’s work—the first quantum generative model for hit discovery!
At Klyne, we build affordable tools for drug discovery:
✨ Pay-as-you-go (no licensing fees, ~10x cheaper)
💡 Expert team for every stage
📩 [[email protected]]
Thrilled to welcome @akshatai.bsky.social to Klyne! 🚀
Stay tuned for exciting science updates. Have biotech questions or needs? We're here to help: [email protected]
Stay tuned for exciting science updates. Have biotech questions or needs? We're here to help: [email protected]
Excited to share some news this New Year! I’ll be joining @klyneai.bsky.social as CTO soon.
We co-founded Klyne to revolutionize biotech with cost-effective, no-licensing-fee software solutions. 🚀
If you're interested in screening, hit optimization, or FEP calculations, reach out: [email protected] 😉
We co-founded Klyne to revolutionize biotech with cost-effective, no-licensing-fee software solutions. 🚀
If you're interested in screening, hit optimization, or FEP calculations, reach out: [email protected] 😉
January 1, 2025 at 6:45 AM
Thrilled to welcome @akshatai.bsky.social to Klyne! 🚀
Stay tuned for exciting science updates. Have biotech questions or needs? We're here to help: [email protected]
Stay tuned for exciting science updates. Have biotech questions or needs? We're here to help: [email protected]